Post by peryannie4 on May 28, 2021 4:45:48 GMT -5
Inotuzumab is a monotherapy to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Each vial contains inotuzumab 1 mg. It is a white to off white lyophilised powder .It should be given and administered under the experienced and professional supervision. Patient should be administered for at least 1 hour after the infusion.